|
|
|
Sort Order |
|
|
|
Items / Page
|
|
|
|
|
|
|
| Srl | Item |
| 1 |
ID:
067372
|
|
|
| 2 |
ID:
151191
|
|
|
|
|
| Summary/Abstract |
How do algorithms shape the imaginary and practice of security? Does their proliferation point to a shift in the political rationality of security? If so, what is the nature and extent of that shift? This article argues that efforts to strengthen global health security are major drivers in the development and proliferation of new algorithmic security technologies. In response to a seeming epidemic of potentially lethal infectious disease outbreaks – including HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), pandemic flu, Middle East Respiratory Syndrome (MERS), Ebola and Zika – governments and international organizations are now using several next-generation syndromic surveillance systems to rapidly detect new outbreaks globally. This article analyses the origins, design and function of three such internet-based surveillance systems: (1) the Program for Monitoring Emerging Diseases, (2) the Global Public Health Intelligence Network and (3) HealthMap. The article shows how each newly introduced system became progressively more reliant upon algorithms to mine an ever-growing volume of indirect data sources for the earliest signs of a possible new outbreak – gradually propelling algorithms into the heart of global outbreak detection. That turn to the algorithm marks a significant shift in the underlying problem, nature and role of knowledge in contemporary security policy.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3 |
ID:
165328
|
|
|
|
|
| Summary/Abstract |
This article advances a new account of security as an intensely relational and ontologically entangled phenomenon that does not exist prior to, nor independently of, its intra-action with other phenomena and agencies. Security's ‘entanglement’ is demonstrated through an analysis of the protracted security concerns engendered by ‘dangerous’ scientific experiments performed with lethal H5N1 flu viruses. Utilising methodological approaches recently developed in the field of Science and Technology Studies (STS), the article explicates the intensely ‘co-productive’ dynamics at play between security and science in those experiments, and which ultimately reveal security to be a deeply relational phenomenon continuously emerging out of its engagement with other agencies. Recovering this deeper ontological entanglement, the article argues, necessitates a different approach to the study of security that does not commence by fixing the meaning and boundaries of security in advance. Rather, such an approach needs to analyse the diverse sites, dynamics, and processes through which security and insecurity come to intra-actively materialise in international relations. It also demands a fundamental reconsideration of many of the discipline's most prominent security theories. They are not merely conceptual tools for studying security, but crucial participants in its intra-active materialisation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4 |
ID:
049588
|
|
|
|
|
| Publication |
London, Routledge, 2003.
|
| Description |
xii, 168p.
|
| Series |
Routledge advances in European politics; 11
|
| Standard Number |
0415369754
|
|
|
|
|
|
|
|
|
|
|
|
Copies: C:1/I:0,R:0,Q:0
Circulation
| Accession# | Call# | Current Location | Status | Policy | Location |
| 047291 | 306.094/ELB 047291 | Main | On Shelf | General | |
|
|
|
|
| 5 |
ID:
141063
|
|
|
|
|
| Summary/Abstract |
Pharmaceuticals are now critical to the security of populations. Antivirals, antibiotics, next-generation vaccines, and antitoxins are just some of the new ‘medical countermeasures’ that governments are stockpiling in order to defend their populations against the threat of pandemics and bioterrorism. How has security policy come to be so deeply imbricated with pharmaceutical logics and solutions? This article captures, maps, and analyses the ‘pharmaceuticalisation’ of security. Through an in-depth analysis of the prominent antiviral medication Tamiflu, it shows that this pharmaceutical turn in security policy is intimately bound up with the rise of a molecular vision of life promulgated by the biomedical sciences. Caught in the crosshairs of powerful commercial, political, and regulatory pressures, governments are embracing a molecular biomedicine promising to secure populations pharmaceutically in the twenty-first century. If that is true, then the established disciplinary view of health as a predominantly secondary matter of ‘low’ international politics is mistaken. On the contrary, the social forces of health and biomedicine are powerful enough to influence the core practices of international politics – even those of security. For a discipline long accustomed to studying macrolevel processes and systemic structures, it is in the end also our knowledge of the minute morass of molecules that shapes international relations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6 |
ID:
144247
|
|
|
|
|
| Summary/Abstract |
The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines. This article identifies three mechanisms that interlink these trends. First, securitisation encourages technological policy responses. Second, it creates an exceptional political space in which pharmaceutical development can be freed from constraints. Third, it creates an institutional architecture that facilitates pharmaceutical policy responses. The ways in which the securitisation of health reinforces pharmaceutical policy strategies must, the article concludes, be included in ongoing efforts to evaluate them normatively and politically.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7 |
ID:
081452
|
|
|
|
|
| Publication |
2008.
|
| Summary/Abstract |
This article analyses the conjunctures of risk and security that have recently emerged in the securitization of HIV/AIDS. Although these partially corroborate Ulrich Beck's notion of risk society, important elements of the securitization of HIV/AIDS resist his understanding of risk as a `danger of modernization'. The article therefore turns to François Ewald's alternative theorization of risk as a `neologism of insurance', and shows that insurance is a risk-based security practice widely used to manage the welfare of populations. Such a biopolitical approach to risk is also valuable for analysing the securitization of HIV/AIDS, which, even though it is unfolding outside the domain of insurance, similarly draws upon multiple risk categories (`security risks', `risk groups' and `risk factors') in efforts to improve the collective health of populations. Analysed through a wider concept of risk as a `biopolitical rationality', the conjuncture of risk and security in the securitization of HIV/AIDS thus emerges as a principal site where the institutions of sovereign power in international relations are being absorbed and integrated within a wider biopolitical economy of power.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 8 |
ID:
134474
|
|
|
|
|
| Summary/Abstract |
Governments in Europe and around the world amassed vast pharmaceutical stockpiles in anticipation of a potentially catastrophic influenza pandemic. Yet the comparatively ‘mild’ course of the 2009 H1N1 pandemic provoked considerable public controversy around those stockpiles, leading to questions about their cost–benefit profile and the commercial interests allegedly shaping their creation, as well as around their scientific evidence base. So, how did governments come to view pharmaceutical stockpiling as such an indispensable element of pandemic preparedness planning? What are the underlying security rationalities that rapidly rendered antivirals such a desirable option for government planners? Drawing upon an in-depth reading of Foucault’s notion of a ‘crisis of circulation’, this article argues that the rise of pharmaceutical stockpiling across Europe is integral to a governmental rationality of political rule that continuously seeks to anticipate myriad circulatory threats to the welfare of populations – including to their overall levels of health. Novel antiviral medications such as Tamiflu are such an attractive policy option because they could enable governments to rapidly modulate dangerous levels of (viral) circulation during a pandemic, albeit without disrupting all the other circulatory systems crucial for maintaining population welfare. Antiviral stockpiles, in other words, promise nothing less than a pharmaceutical securing of circulation itself.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 9 |
ID:
050355
|
|
|
|
|
| Publication |
London, International Institute for Strategic Studies, 2003.
|
| Description |
78p.
|
| Series |
Adelphi Paper; 357
|
| Standard Number |
0198529120
|
|
|
|
|
|
|
|
|
|
|
|
Copies: C:1/I:0,R:0,Q:0
Circulation
| Accession# | Call# | Current Location | Status | Policy | Location |
| 047526 | 355.03356/ELB 047526 | Main | On Shelf | General | |
|
|
|
|
|
|
|
|
|